Ray Co

Ray Co CapEx/OCF

The CapEx to Operating Cash Flow Ratio of Ray Co (228670.KQ) as of Nov 18, 2026 is 28.19 %. In the previous year, CapEx to Operating Cash Flow Ratio was 1,513.61 % — a change of -98.14% (lower).

CapEx/OCF

28.19 %

YoY

-98.14%

Last updated:

CapEx to Operating Cash Flow Ratio of Ray Co is 2025 28.19 % . CapEx to Operating Cash Flow Ratio of Ray Co was 2024 1,513.61 % . It decreases by -98.14% lower compared to the previous year.

The Ray Co CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2018
53.22 KRW
Jan 1, 2019
21.43 KRW
Jan 1, 2020
166.13 KRW
Jan 1, 2021
209.49 KRW
Jan 1, 2022
-397.37 KRW
Jan 1, 2023
-11.64 KRW
Jan 1, 2024
1,513.61 KRW
Jan 1, 2025
28.19 KRW
The Ray Co CapEx/OCF history
YEARCapEx/OCFYoY
28.19 %-98.14%
1,513.61 %-13,103.50%
-11.64 %-97.07%
-397.37 %-289.69%
209.49 %+26.10%
166.13 %+675.27%
21.43 %-59.73%
53.22 %-79.50%
259.64 %-42.58%
452.18 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ray Co Stock analysis

What does Ray Co do? Ray Co., Ltd. generates revenue through the manufacturing and sale of advanced technology medical devices, focusing on digital diagnostic systems and digital therapy solutions. The company produces dental radiography equipment such as x-ray systems and cone beam computed tomography (CBCT) systems, alongside 3D scanning, dental computer aided design (CAD), and 3D printers for prosthodontics, orthodontics, and implant surgery. Domestic and overseas markets purchase these products, with the company operating through subsidiaries to distribute its offerings globally. Digital diagnostic systems like dental radiography equipment and CBCT systems are sold to healthcare providers and dental clinics, while digital therapy solutions including 3D scanning and CAD systems target dental laboratories and surgical centers. The firm's product portfolio serves both domestic and international clients, leveraging its subsidiaries for global distribution channels. Ray Co., Ltd. emphasizes advanced technology in its medical device offerings, with digital therapy solutions such as 3D printers and CAD systems being key revenue drivers. The company's focus on dental-specific applications ensures targeted sales to specialized healthcare segments, including prosthodontics, orthodontics, and implant surgery practices. Ray Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ray Co stock

CapEx to Operating Cash Flow Ratio of Ray Co is 28.19 % in 2025.

CapEx to Operating Cash Flow Ratio of Ray Co changed from 1,513.61 % to 28.19 %, representing a -98.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio Ray Co since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's Ray Co with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Ray Co

All Key Metrics — Ray Co